Aptevo Therapeutics Inc. (APVO) Shareholders’ equity 2016–2023
Aptevo Therapeutics Inc. (APVO) shareholders’ equity at each fiscal year-end, per SEC filings.
$18.0MFY2023 · since FY2016: $88.6M → $18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $18.0M | +1378.1% |
| FY2022 | $1.2M | -92.7% |
| FY2021 | $16.6M | +40.1% |
| FY2020 | $11.8M | -61.1% |
| FY2019 | $30.4M | -62.9% |
| FY2018 | $82.0M | +62.2% |
| FY2017 | $50.6M | -42.9% |
| FY2016 | $88.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice